Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1991
[Intermediary and substitution criteria in the development of anti-arrhythmia agents]M Lièvre, A Leizorovicz, J P BoisselJournal of Cardiovascular Pharmacology|January 1, 1992
Coronary reperfusion rates in acute myocardial infarction patients after thrombolytic treatment with anistreplase: correlation with the delay from onset of symptoms to treatment: a review of 424 case records of patients admitted to coronary reperfusion studies with anistreplaseA Leizorovicz, J P Boissel, F RobertDrugs|January 1, 1987
A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusionsA Leizorovicz, G Durrieu, J P BoisselVascular Medicine (London, England)|April 25, 2003
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study)Paul T Vaitkus, A Leizorovicz, S Z Goldhaber, et al.Fundamental & Clinical Pharmacology|January 1, 1987
Relationship between plasma mexiletine levels at steady-state. Presence of ventricular arrhythmias and side effectsJ C Peyrieux, J P Boissel, A LeizoroviczThrombosis Research|March 1, 1992
Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study GroupL Bara, A Leizorovicz, H Picolet, et al.Cardiovascular Drugs and Therapy|October 24, 1998
A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol StudyP Levy, P Lechat, A Leizorovicz, et al.Journal of Thrombosis and Haemostasis : JTH|August 9, 2011
No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudyV Siguret, I Gouin-Thibault, E Pautas, et al.Diabete & Metabolisme|September 1, 1994
[Quality of life of patients during treatment of type I diabetes. Importance of a questionnaire focused on the subjective quality of life]A Dazord, A Leizorovicz, P Gerin, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 12, 1983
[Non-steroidal anti-inflammatory agents. Evaluation criteria in discal sciatic neuralgia]H Decousus, J P Boissel, A Leizorovicz, et al.Pageof 7